Stereotaxis (STXS) EPS (Diluted) (QoQ) (2011 - 2026)
Analysis
Stereotaxis (STXS) EPS (Diluted) (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.94% |
| Dec 31, 2025 | 12.79% |
| Sep 30, 2025 | -56.50% |
| Jun 30, 2025 | 32.62% |
| Mar 31, 2025 | 24.02% |
| Dec 31, 2024 | -21.17% |
| Sep 30, 2024 | -4.30% |
| Jun 30, 2024 | -25.64% |
| Mar 31, 2024 | 13.05% |
| Dec 31, 2023 | 3.68% |
| Sep 30, 2023 | -5.99% |
| Jun 30, 2023 | 12.03% |
| Mar 31, 2023 | -25.68% |
| Dec 31, 2022 | 14.49% |
| Sep 30, 2022 | 4.08% |
| Jun 30, 2022 | -23.69% |
| Mar 31, 2022 | -19.10% |
| Dec 31, 2021 | 25.36% |
| Sep 30, 2021 | -219.99% |
| Jun 30, 2021 | 17.51% |